Abstract
Pneumolysin, a membrane-damaging toxin, is known to activate the classical complement pathway. We have shown that 1 microgram ml-1 of pneumolysin can activate complement, which is a much lower level than observed previously. We have identified two distinct regions of pneumolysin which show homology with a contiguous sequence within acute-phase proteins, including human C-reactive protein (CRP). Site-directed mutagenesis of the pneumolysin gene was used to change residues common to pneumolysin and CRP. Some of the modified toxins had a reduced ability both to activate complement and bind antibody. We suggest that the ability of pneumolysin to activate complement is related to its ability to bind the Fc portion of immunoglobulin G.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Bacterial Proteins
-
C-Reactive Protein / chemistry*
-
Complement Activation / immunology*
-
Cytotoxins / chemistry
-
Cytotoxins / genetics
-
Cytotoxins / immunology*
-
Cytotoxins / metabolism
-
Enzyme-Linked Immunosorbent Assay
-
Humans
-
Immunoglobulin Fc Fragments / metabolism
-
Immunoglobulin G / metabolism
-
Molecular Sequence Data
-
Mutagenesis, Site-Directed
-
Rabbits
-
Radioimmunoassay
-
Recombinant Proteins / genetics
-
Recombinant Proteins / immunology
-
Recombinant Proteins / metabolism
-
Sequence Alignment
-
Streptococcus pneumoniae / metabolism
-
Streptolysins / chemistry
-
Streptolysins / genetics
-
Streptolysins / immunology*
-
Streptolysins / metabolism
Substances
-
Bacterial Proteins
-
Cytotoxins
-
Immunoglobulin Fc Fragments
-
Immunoglobulin G
-
Recombinant Proteins
-
Streptolysins
-
plY protein, Streptococcus pneumoniae
-
C-Reactive Protein